What does this research mean for the field?

Fluorine incorporation into small-molecule drugs significantly enhances their metabolic stability, lipophilicity, target interactions, and pharmacokinetic profiles. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The research aims to explore the significance and applications of fluorine-containing small-molecule drugs approved by the FDA by 2025.

March 15, 2026RSC Advances10 citationsOpen Access

Fluorine-containing FDA-approved small-molecule drugs in 2025: significance, synthetic insights, and therapeutic applications

SMShweta MishraIFTM University CJChetna Jadala SCSavio CardozaUniversity of Arizona

Puntos clave

The research aims to explore the significance and applications of fluorine-containing small-molecule drugs approved by the FDA by 2025.
Analyzed the incorporation of fluorine into small-molecule drugs.
Reviewed therapeutic applications and implications for drug design.
Investigated synthetic strategies for fluorine-containing compounds.
Fluorine enhances the metabolic stability and lipophilicity of drugs.
Improved target interactions observed with fluorine incorporation.
The pharmacokinetic profile is significantly affected by fluorine in drug design.

Resumen

Fluorine has been widely incorporated into small-molecule drugs as an effective strategy to modulate metabolic stability, lipophilicity, target interactions, and overall pharmacokinetic profile.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo